אינג'י 10 מג80 מג טבליות

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

EZETIMIBE; SIMVASTATIN

Mevcut itibaren:

MERCK SHARP & DOHME ISRAEL LTD

ATC kodu:

C10AA01

Farmasötik formu:

טבליה

Kompozisyon:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

Uygulama yolu:

פומי

Reçete türü:

מרשם נדרש

Tarafından üretildi:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Terapötik grubu:

SIMVASTATIN

Terapötik alanı:

SIMVASTATIN

Terapötik endikasyonlar:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Yetkilendirme tarihi:

2012-04-30